Healthcare is a systemic issue.

Editor's Note:

The starting point of this column is a question that has made me think repeatedly:
In almost every public discussion about healthcare, we talk about technology—AI diagnostics, precision medicine, digital platforms, blockchain evidence storage, cloud data. These terms describe tools. But before the discussion of tools drowns out everything else, a more fundamental question has almost never been answered directly:
When a person walks into the clinic, at the most vulnerable moment when she needs to be caught, who decides whether she can be caught?
This is not a technical problem. This is a systemic problem.

Why "medical sovereignty"?
GFM launched the "Healthcare Sovereignty" column not to add a new direction to its medical reporting, nor to repackage healthcare as a new technology sector. What we want to do is put healthcare back in its rightful place.
Healthcare is not just a health issue, not just an efficiency issue, and not just a technology issue. It is first and foremost a systemic issue, a question of who has the power to make decisions, who has the right to access data, and who can initiate corrective measures when the system fails.

(Image caption) A nearly empty medical space: well-lit and orderly, yet individuals may still not be "caught" within it. The existence of a healthcare system does not mean that the system is activated at every moment.

When individuals lose their right to choose in the face of illness—because of language, because of information asymmetry, because of the lack of room for them in the design of the system—medical care is no longer just about treatment, but becomes a kind of institutional allocation and control.
When a family loses the ability to pay for insurance, and when a society loses the ability to judge and refuse in terms of data, platforms, and capital structures, the loss of healthcare sovereignty is no longer an abstract policy discussion, but a reality that every individual directly experiences in their most vulnerable moments.
Understanding this reality is the reason for the existence of "Medical Sovereignty".

The first season of "Healthcare Sovereignty" unfolds through two real-life stories, because we believe that systemic issues can only be truly understood through the experiences of real people.
The first main storyline is Nora's personal experience.
She wasn't just a symbol, a case number. She was a person with a name, a medical history, and referral documents, who walked into a consultation room on a cold afternoon, filled with anxiety about massive bleeding, and then walked out almost in tears. She did everything a patient could prepare before entering the medical system, but that door still closed in front of her.
A few hours later, a call from the insurance company changed the outcome. But that call was predicated on her knowing she could make the call, having the ability to do so, and that the insurance company's system was functioning properly that day.
Nora's story tells us that while systems have the capacity to correct their errors, this capacity is not equally available to every patient. This inequality is not a matter of luck, but rather a problem with the design of the system.
The second main thread is Dr. Chen Jiarui's institutional experiment.
If Nora represents how patients experience the system, Chen Jiarui represents a professional who has long been within the system, and how, after becoming a patient, he decides to start from the bottom and ask questions again. He said, "Even as a doctor, finding the right specialist, retrieving the images, and going through the procedures is still like navigating a maze."
A chief orthopedic surgeon with thirty years of clinical experience witnessed a system design that was not patient-centered in his own patient experience. He then invested ten years and $140 million of his personal funds in an attempt to build a different structure.
The results of this experiment are still unknown. But his awareness of the problem, and Nora's experience, point to the same fundamental question: can the underlying rules of healthcare be redesigned?

The seven articles in the first season revolve around these two main themes, forming an analytical loop that extends from individuals to institutions and from the United States to the world.
Nora's story serves as an entry point. It takes the reader into the specific experiences of a particular person, and then we unfold outwards layer by layer from that experience: the formation mechanism of institutional fissures, the ownership of control over medical records, the power logic behind referral mechanisms, the systemic penetration of AI, insurance capital, and pharmaceutical companies into medical decision-making, and finally return to a concluding proposition: what is truly scarce is the ability to judge when to use technology and when to reject it.
Chen Jiarui's story serves as a contrast. It illustrates the structural obstacles faced by system builders with a clear awareness of problems in real business and institutional environments. Our record of AiTmed is not brand reporting, but an ongoing institutional observation—whether its claims are validated, whether its design truly returns control to patients—these questions require time and actual data to answer.
Together, the seven articles cover the legal framework for language assistance, a comparison of global medical record sovereignty, a power analysis of referral mechanisms, and the industry landscape of insurance, pharmaceutical companies, AI, and technology platforms. Each article can be read independently, but together they form a complete analytical framework upon which readers can build their own judgments.

To be honest, there are a few questions that the series didn't answer, and the first season didn't fully address them.
The issue of healthcare sovereignty in the Global South—when a country lacks even a basic medical record system, the question of "who owns your medical records" takes on a completely different meaning. This will be the central focus of the second season.
The issue of drug accessibility sovereignty—the price of a drug in the United States is three to ten times that in Germany—the institutional roots and political consequences of this gap are only touched upon in the first season, without being systematically explored.
And the specific sovereignty challenges of AI in healthcare in resource-scarce environments—when an African country's medical AI training data comes from the United States, and when the speed of technology deployment far exceeds the speed of institutional response, how does the loss of sovereignty quietly occur in everyday technology procurement decisions?
These issues are all covered in our record-keeping plan.

(Image caption) Healthcare is not just about clinics and doctors, but a complex network of systems comprised of data, insurance, referrals, platforms, and decision-making mechanisms. What truly determines an individual's fate is often not a single medical act, but how this system operates.

Finally, one of my personal observations while organizing the first season is that Nora's phone call at 5:24 PM is a moment that I kept thinking about.
The phone call changed the outcome for several conditions to be met simultaneously: she knew she could file a complaint, she had the ability to communicate by phone, her insurance covered the response mechanism, and the staff on duty that day took her statement seriously.
If any one condition is not met, the result will be different.
This "failure of any one condition" occurs daily for countless patients in global healthcare systems. It doesn't appear in any institution's annual report, nor does it constitute any policy indicator, but it is the most real and commonplace manifestation of the failure of healthcare sovereignty.
What we can do is record it and make it visible.
Because visibility is a prerequisite for change.

Editor-in-Chief

The first season of "Healthcare Sovereignty" consists of seven articles, produced by the GFM editorial team. This column is continuously updated, and the second season is in preparation. For any comments or additions, please contact the editorial team through official GFM channels.